Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19

NCT06197217 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1350

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate COVID-19

Interventions

DRUG: WPV01
DRUG: Placebo

Sponsor

Westlake Pharmaceuticals (Hangzhou) Co., Ltd.